(Q37894600)

English

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments

scientific article published on 26 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments (English)

1 reference

Europe PubMed Central

24 August 2017

amyotrophic lateral sclerosis

0 references

Abraham Acevedo-Arozena

object named as

Abraham Acevedo-Arozena

5

0 references

Elizabeth M. C. Fisher

4

object named as

Elizabeth M C Fisher

1 reference

Europe PubMed Central

24 August 2017

author name string

Peter I Joyce

1

1 reference

Europe PubMed Central

24 August 2017

Pietro Fratta

2

1 reference

Europe PubMed Central

24 August 2017

Pietro Fratta

3

1 reference

Europe PubMed Central

24 August 2017

publication date

26 June 2011

1 reference

Europe PubMed Central

24 August 2017

number of pages

29

1 reference

based on heuristic

inferred from page(s)

Mammalian Genome

1 reference

Europe PubMed Central

24 August 2017

22

1 reference

Europe PubMed Central

24 August 2017

7-8

1 reference

Europe PubMed Central

24 August 2017

420-448

1 reference

Europe PubMed Central

24 August 2017

https://scigraph.springernature.com/pub.10.1007/s00335-011-9339-1

0 references

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Neurotoxic effects of TDP-43 overexpression in C. elegans

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Oxidative stress in ALS: key role in motor neuron injury and therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Lost in translation: treatment trials in the SOD1 mouse and in human ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Deficits in axonal transport precede ALS symptoms in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Loss of functional prion protein: a role in prion disorders?

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Multiple roles of HDAC inhibition in neurodegenerative conditions.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Canine degenerative myelopathy.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Manganese porphyrin given at symptom onset markedly extends survival of ALS mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Phase 2 study of sodium phenylbutyrate in ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Toward more efficient clinical trials for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Role of axonal transport in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The pharmacology and mechanism of action of riluzole

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Lithium delays progression of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 A315T mutation in familial motor neuron disease

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ultrastructural diversity of inclusions and aggregations in the lumbar spinal cord of SOD1-G93A transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Exome sequencing reveals VCP mutations as a cause of familial ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Aggregation modulating elements in mutant human superoxide dismutase 1.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mitochondrial dysfunction and intracellular calcium dysregulation in ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Caspases in apoptosis and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A Drosophila model for TDP-43 proteinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Redox modifier genes in amyotrophic lateral sclerosis in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutations of optineurin in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Alzheimer disease: progress or profit?

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Effects of riluzole on N-methyl-D-aspartate-induced tyrosine phosphorylation in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutant dynactin in motor neuron disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Motor neuron regeneration in adult zebrafish

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1(G93A) mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Neuron-specific overexpression of the co-chaperone Bcl-2-associated athanogene-1 in superoxide dismutase 1(G93A)-transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Design, power, and interpretation of studies in the standard murine model of ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 is a developmentally regulated protein essential for early embryonic development

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mitochondrial fission/fusion dynamics and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Transcriptional unit of the murine Thy-1 gene: different distribution of transcription initiation sites in brain

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Progressive motor weakness in transgenic mice expressing human TDP-43.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Molecular mechanisms of spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Minocycline delays disease onset and mortality in a transgenic model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43-mediated neuron loss in vivo requires RNA-binding activity

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The unfolded protein response in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

TDP-43 mutation in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1G93A-induced motor neuron death

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish

1 reference

https://api.crossref.org/works/10.1007%2FS00335-011-9339-1

21 January 2018

A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Creatine for amyotrophic lateral sclerosis/motor neuron disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Swelling and vacuolisation of mitochondria in transgenic SOD1-ALS mice: a consequence of supranormal SOD1 expression?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of Hsp27 does not influence disease in the mutant SOD1G93Amouse model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identified motoneurons and their innervation of axial muscles in the zebrafish

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutathione metabolism and oxidative stress in neurodegeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase-1 mutant mouse in vivo: evidence for increased persistent inward currents

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CaMKII function in the nervous system explored from a genetic perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructural study of the synapses of central chromatolytic anterior horn cells in motor neuron disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetics of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloride influx aggravates Ca2+-dependent AMPA receptor-mediated motoneuron death.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excitability properties of mouse motor axons in the mutant SOD1(G93A) model of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21706386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00335-011-9339-1

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37894600&oldid=2090395566"